Health TrialsbyHealthPanel

Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels

ConditionHypovitaminosis D
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAzienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

About this trial

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Hypovitaminosis D (<20ng/mL)

Disqualifiers

Osteoporosis (T score <-2.5SD)

Renal or hepatic diseases

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vitamin D

    Dietary supplement

    Vitamin D

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Calcifediol each monthExperimental treatment 1 intervention
Group B: Cholecalciferol 25.000 UIExperimental treatment 1 intervention
Group C: Calcifediol 4 drops each dayExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

level of Vitamin D

Blood dosage of Vitamin D

Time frame
Between recruitment and 1 month
2

level of Vitamin D

Blood dosage of vitamin D

Time frame
Between recruitment and 6 month

Secondary outcomes

1

DEXA

DEXA is a radiographic measurement of Bone Mass

Time frame
Between recruitment and 18 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Lead sponsor

Silvana De Giorgi

Collaborator

Davide Bizzoca

Collaborator

Angela Notarnicola

Collaborator

Source ClinicalTrials.gov
Apply now